Skip to main content
Caplight Logo









iOncologi

iOncologi

Private
Gainesville, FloridaHealthcare & Life Scienceshttps://ioncologi.com

Last Round

Seed

May 23, 2025

Total Funding Raised

$3.25M

Company Overview

iOncologi operates in Healthcare & Life Sciences and is based in Gainesville, Florida. Its latest recorded funding round was a Seed round in May 2025.

iOncologi, Inc. is a biotechnology company that develops immunotherapies for the treatment of refractory cancers and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

iOncologi Comparables

Compare iOncologi with similar companies based on industry and business-model similarity.

iOncologi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MimiVax Inc.
83%
Diakonos Oncology
80%
Hemispherian AS
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

iOncologi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 23, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

iOncologi Investors

Notable investors and investment history

iOncologi investors
InvestorRounds
UF Innovate | VenturesSeed
University of Florida VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors increased 60% MoM.

  • Oct 19, 2025

    Findings validating UNIFYRs technology published in Nature Biomedical Engineering.

Book a demo to see all signals

For institutional investors. Book with your work email.

iOncologi Filings

Explore SEC and related filing metadata, where available.

iOncologi filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about iOncologi's valuation, stock price, and market status.

Is iOncologi a public or private company?

iOncologi is a private company.

What is the current stock price of iOncologi?

iOncologi is a private company, so its shares have no public market price. Caplight tracks iOncologi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is iOncologi worth (valuation)?

Valuation information for iOncologi is not publicly available.

Can I buy iOncologi stock?

iOncologi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was iOncologi's last funding round?

iOncologi's most recent funding round was Seed on May 23, 2025.

Who are the main investors in iOncologi?

Key investors in iOncologi include UF Innovate | Ventures, University of Florida Ventures.

Will iOncologi IPO soon?

No public IPO plans have been announced for iOncologi.

How can I track iOncologi secondary market activity?

Caplight tracks bids, offers, and trades in iOncologi's shares on secondary markets.

Firmographic Details

HeadquartersGainesville, Florida
Employee Range1
Year Founded2017
Last FundingMay 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?